CD8A and breast carcinoma: In support, the higher immature B cell count, higher CD4+ central memory T cell count, and lower CD8+ naive T cell count among breast cancer survivors, which were significantly different between groups, were lost when controlling for age, but–importantly (see next paragraph)—were not lost when controlling for CMV serostatus.